This pilot study analyzes the cost savings of utilizing a prescription medical food, serum-derived bovine immunoglobulin/protein isolate, for the management of inflammatory bowel disease in a small cohort.
Patricia Burgunder, ARNP
Advertisement
Articles by Patricia Burgunder, ARNP
Advertisement
Latest Updated Articles
- Pilot Pharmacoeconomic Analysis of Serum-derived Bovine Immunoglobulin Use in IBD
Published: April 20th 2016 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
CDC Layoffs Raise Questions About the Future of Public Health Surveillance
2
From $200,000 in Student Loan Debt to Becoming a 7-Figure Pharmacist
3
Inhaled Insulin Demonstrates Comparable Safety, Lung Function, and Efficacy to Injectable Insulin in Type 1 Diabetes
4
FDA Approves Updated Indication for Upadacitinib in Patients With IBD
5
